Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement

for
Stroke, Hypertension, Home Blood Pressure Monitoring,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 35+

Code: NCT07091851

Recruiting

Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (SLL)
Location: Boston MA, New York NY
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06849713

Phase 2, Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase 1, Phase 2, Recruiting

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Boston MA, Pittsburgh PA, Houston TX, Los Angeles CA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05019716

Phase 1, Phase 2, Recruiting

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

for
Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07014293

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase 2, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Boston MA, The Bronx NY, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase 3, Recruiting

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

for
Dry Eye Disease (DED)
Location: Andover MA
Sponsor: Andover Research Eye Institute

Sex: All

Age: 18+

Code: NCT07676084

Recruiting

Re-Engineered Discharge for Diabetes Care Transitions

for
Diabetes Mellitus Type 2, Social Determinants of Health (SDOH),
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 18+

Code: NCT06869057

Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase 1, Phase 2, Recruiting

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

for
Basal Ganglia Intracerebral Hemorrhage
Location: Burlington MA, New Haven CT, New York NY,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70+

Code: NCT07260916

Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase 1, Recruiting

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, Durham NC, Chapel Hill NC, Cincinnati OH,
Sponsor: Prolexys Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01695590

Phase 1, Phase 2, Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

for
Cancer Risk, Cancer Predisposition Syndrome,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0+

Code: NCT05463796

Recruiting

Improving Spatial Perception and Speech Understanding in Multitalker Mixtures

for
Hearing Loss
Location: Boston MA
Sponsor: Boston University Charles River Campus

Sex: All

Age: 18 - 70+

Code: NCT05260307

Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Brighton MA, Milford MA, Portsmouth NH, Stony Brook NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

for
Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Location: Boston MA
Sponsor: Boston University Charles River Campus

Sex: All

Age: 50 - 70+

Code: NCT07659964

Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Fall River MA, East Syracuse NY, Horseheads NY,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase 3, Recruiting

Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease

for
Chronic Kidney Disease (Stages 4 and 5),
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07186218

Recruiting

A Study of PYX-201 in Advanced Solid Tumors

for
Solid Tumor, Advanced Solid Tumor
Location: Boston MA, Providence RI, New York NY, Philadelphia PA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT05720117

Phase 1, Recruiting